|
FORT LAUDERDALE, Fla.(BUSINESS WIRE)
MEDNAX, Inc., (NYSE: MD) today announced the acquisition of Maryland
Perinatal Associates, PC, a group of four maternal-fetal medicine
physicians based in Rockville, Maryland.
Maryland Perinatal Associates also includes more than 45 clinical and
administrative support staff who work with the physicians providing care
to expectant mothers, including the management of high-risk and
complicated pregnancies, in communities throughout Maryland. Maryland
Perinatal Associates has four offices, and relationships with four area
hospitals in Rockville, Frederick, Silver Springs and Takoma Park,
Maryland.
The group will practice as part of MEDNAX's Pediatrix Medical Group, a
national group practice that consists of the nation's leading neonatal,
maternal-fetal medicine and pediatric cardiology physicians, as well as
other pediatric subspecialists. Pediatrix's national group practice
already includes neonatal and pediatric cardiology physician
subspecialists practicing in Maryland and the northern Virginia area.
As part of Pediatrix, we anticipate that our practice will benefit
greatly from the administrative resources and clinical support of a
national group network, both of which are very important factors in our
growth given the consistently increasing demand for maternal-fetal
services in our community,? said Wayne Kramer, M.D., who will serve as
Pediatrix's medical director for the practice. From a patient care
perspective, we will have the opportunity to collaborate directly with
Pediatrix's pediatric cardiology and neonatal subspecialists to provide
a continuum of care model that we believe will help us further improve
outcomes for our patients and their families.?
MEDNAX paid cash for the practice, and the transaction is expected to be
immediately accretive to its earnings. No additional terms of the
transactions were disclosed.
With this acquisition, MEDNAX has announced four physician group
practice acquisitions in 2010.
ABOUT MEDNAX
MEDNAX, Inc., is a national medical group that comprises the nation's
leading provider of neonatal, maternal-fetal and pediatric physician
subspecialty services as well as anesthesia services. Physicians and
advanced practitioners practicing as part of MEDNAX are reshaping the
delivery of care within their specialties and subspecialties, using
evidence-based tools, continuous quality initiatives and clinical
research to enhance patient outcomes and provide high-quality,
cost-effective care. Pediatrix Medical Group, a unit of MEDNAX, was
founded in 1979 and now includes neonatal physicians who provide
services at more than 275 neonatal intensive care units, who collaborate
with affiliated maternal-fetal medicine, pediatric cardiology and
pediatric intensivist physician subspecialists to provide a clinical
care continuum. Pediatrix is also the nation's largest provider of
newborn hearing screens. In 2007, the Company expanded into anesthesia
services. Today, American Anesthesiology includes more than 550
anesthesiologists and advanced practitioners. MEDNAX, through its
affiliated professional corporations, employs more than 1,450 physicians
in 33 states and Puerto Rico. Additional information is available at www.mednax.com.
Certain statements and information in this press release may be
deemed to contain forward-looking statements which may include, but are
not limited to, statements relating to our objectives, plans and
strategies, and all statements, other than statements of historical
facts, that address activities, events or developments that we
intend, expect, project, believe or anticipate will or may occur in the
future. These statements are often characterized by terminology such as
believe?, hope?, may?, anticipate?, 'should?, intend?, plan?,
will?, expect?, estimate?, project?, positioned?, 'strategy? and
similar expressions, and are based on assumptions and assessments made
by MEDNAX's management in light of their experience and their perception
of historical trends, current conditions, expected future developments
and other factors they believe to be appropriate. Any forward-looking
statements in this press release are made as of the date hereof, and
MEDNAX undertakes no duty to update or revise any such statements,
whether as a result of new information, future events or otherwise.
Forward-looking statements are not guarantees of future performance and
are subject to risks and uncertainties. Important factors that could cause
actual results, developments, and business decisions to differ
materially from forward-looking statements are described in MEDNAX's
most recent Annual Report on Form 10-K and its Quarterly Reports on Form
10-Q, including the sections entitled Risk Factors?, as well MEDNAX's
current reports on Form 8-K, filed with the Securities and
Exchange Commission.
MEDNAX, Inc.
Bob Kneeley, Director, Investor Relations,
954-384-0175 x 5300
bob-kneeley@mednax.com
Source: MEDNAX, Inc.
|
